|
We Are Hunting For You!! Sign Up For Our Free Newsletter Today!! CBAI "Cord Blood America Finalizes Cord Blood Stem Cell Processing and Storage Agreement with BioCells, a Major South American Company"
(M2 PressWIRE Via Acquire Media NewsEdge) Stock Hunter PRESENTS : (OTCBB: CBAI) Cord Blood America, Inc., (OTCBB: TPLM) Triangle Petroleum Corp., (OTCBB: NWBO) Northwest Biotherapeutics, Inc., (OTCBB: NTUR) Natural Blue Resources, Inc., (OTCBB: VSRV) Voiceserve, Inc.
www.Stockhunter.us
To sign up for our free Profiles & Alerts :: visit http://www.StockHunter.us
email us!! info@StockHunter.us
---------------------------
(OTCBB: CBAI - Cord Blood America, Inc.)
LATEST NEWS!!
Cord Blood America Finalizes Cord Blood Stem Cell Processing and Storage Agreement with BioCells, a Major South American Company
LAS VEGAS, Feb 08, 2010 -- Cord Blood America, Inc. (OTCBB: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has finalized an agreement to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.
BioCells is the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD) and 12 locations throughout that country, plus it recently expanded to both Uruguay and Paraguay. "BioCells is an outstanding firm and we are delighted to finalize this agreement," said Matthew Schissler, Cord Blood America co-founder and CEO.
Cord Blood America recently opened its 17,000 square foot stem cell laboratory and headquarters in Las Vegas, near the city's international airport. "This transaction is an excellent example of how we are diversifying our revenue model with our new, increased storage capacity," Mr. Schissler said.
About Cord Blood America Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
---------------------------
(OTCBB: TPLM - Triangle Petroleum Corp.)
LATEST NEWS!!
Triangle Petroleum Announces Acreage Acquisition in the North Dakota Bakken Shale Play and New Strategic Focus Area for U.S. Operations
CALGARY, ALBERTA, Feb 08, 2010 -- Triangle Petroleum Corporation (OTCBB: TPLM) today announced a new strategic initiative in the Bakken Shale play of North Dakota and the acquisition of 4,000 net acres in Williams and McKenzie counties. The company further announced a new partnership with Slawson Exploration, a leading operator in the fairway, aimed at the acquisition and development of acreage in known areas of production from the Middle Bakken and Three Forks formations of the Williston Basin.
Dr. Peter Hill, Chief Executive Officer of Triangle Petroleum commented "The Bakken Shale will be our new core area of operations in the United States. Our efforts here are the result of years of work undertaken prior to my joining Triangle this past November. The focus has been on understanding the geology and science of the play, and the capacity of applied technology to unlock the significant oil and gas reserve potential." Dr. Hill continued "Completion technology and the ability to drill long, carefully directed, horizontal wells have changed the oil business forever. It is my personal belief that the Williston Basin Bakken play will ultimately be proven one of the largest oil accumulations in North America. Further, it appears likely that this play will largely be developed by the smaller independent companies and service sectors who have continued to be the innovators of the play. Our acreage lies within the prime Bakken fairway and we have several large and contiguous blocks in the Rough Rider area and identifiable well locations for our operator to commence drilling later this year." Dr. Hill added "Our business strategy is to directly acquire and develop acreage prospective for capturing the Bakken resource base at attractive margins. Today marks the first step in that strategy and we will continue to grow and develop the business platform needed to deliver both early production and the turn round of Triangle." Slawson Exploration, a privately held company based in Wichita, has been active in the Williston Basin since the 1970s. "Slawson is an ideal partner and we are delighted to be associated with their entire team. They are experienced, have strong local content and knowledge, and are one of the lowest cost, most efficient operators in the business" said Dr. Hill. "We are very excited and look forward to working with them and expanding our joint venture in the coming months." Triangle has identified several areas of interest in the Williston Basin, and is in an ongoing process of evaluating further entry opportunities to the Bakken Shale play.
---------------------------
(OTCBB: NWBO - Northwest Biotherapeutics, Inc.)
LATEST NEWS!!
Northwest Biotherapeutics Inc. Appoints Market Media Connect as Communications Agency of Record
Biotech Company Taps Consultancy for Communications Expertise
BETHESDA, Md., Feb 08, 2010 -- Northwest Biotherapeutics, Inc. (OTCBB: NWBO), a development stage biotechnology company focused on personalized cancer vaccines to enhance immune system responses to tumors, has retained Market Media Connect as their communications agency of record. Led from its Los Angeles headquarters, Market Media Connect will support Northwest's communication objectives as the company moves into the next phase of its development.
"We have spent over a decade developing our technologies and advancing our clinical programs" said Dr. Alton Boynton, Chief Executive Officer of NWBT. "As we continue our own development, and as immune therapies for cancer come of age, we need a well-established agency with a broad base of expertise to help us communicate effectively about our vaccines, our clinical progress and the underlying scientific support. We are confident Market Media Connect is the right agency partner to help us reach the next level in our communication efforts." Currently approved cancer treatments are frequently ineffective, cause undesirable toxic side effects and provide limited clinical benefits. In its novel cancer therapies, Northwest Biotherapeutics mobilizes dendritic cells ('DCs'), which are the master cells of the immune system. Northwest Biotherapeutics' lead products are proprietary dendritic cell vaccines for prostate and brain cancer.
"Northwest Biotherapeutics is well positioned to transform the way the biotech community views cancer treatments," said James Morham, CEO of Market Media Connect. "We look forward to working in tandem with Northwest Biotherapeutics to expand and strengthen their external communications and visibility." About Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kinds associated with chemotherapies, and on a cost-effective basis. The Company has two broad platform technologies: dendritic cell-based vaccines and therapeutic antibodies. The Company is focusing on development of its dendritic cell vaccines. The Company's lead clinical trial is a 240 patient double blind, randomized, placebo controlled Phase II trial in newly diagnosed Glioblastoma multiforme ("GBM"), the most lethal form of brain cancer. The Company has also received clearance from the FDA for a 600+ patient Phase III trial in prostate cancer, and clearance from the FDA for Phase I trials in five other cancers. These programs will require a ramp-up period following additional funding. The Company is also conducting a Phase I/II trial with DCVax(R) for recurrent metastatic ovarian cancer. The Company's second technology platform, involving antibodies to CXCR4, is at the late pre-clinical development stage. For further information about clinical sites and Company information please visit the company web site at www.nwbio.com.
---------------------------
(OTCBB: NTUR - Natural Blue Resources, Inc.)
LATEST NEWS!!
Natural Blue Resources, Inc. Announces Today the Signing of Three Contracts by Enso Steel, Inc. for the Sale of HMS1 Recycled Steel for an Aggregate Sales Price of $13.4 Million to Customers Based in China
SANTA FE, N.M., Feb 8, 2010 -- Natural Blue Resources, Inc. (OTCBB:NTUR) announced today the signing of three contracts by Enso Steel, Inc. for the sale of HMS1 recycled steel for an aggregate sales price of $13.4 million to customers based in China. Natural Blue Steel, LLC, a wholly owned subsidiary of Natural Blue Resources, has associated with Enso Steel, an otherwise unaffiliated company, for the purpose of pursuing opportunities in the recycled steel business, and arranged for the sale of the recycled steel under the contracts. Natural Blue Steel will continue its association with Enso Steel to seek out similar market opportunities and transactions in the future. According to Enso President Robert Hunt, the sale is the first in a series of transactions for Natural Blue Steel to become a premier provider of HMS steel products to China, the world's number one consumer of HMS recycled steel. Mr. Hunt commented, "Natural Blue Steel has located vast quantities of steel product and we are well on our way to forging long term relationships with large end users throughout Asia. We believe this business will be a rapidly growing segment for Natural Blue Steel as we expand our product offerings and our strategic relationships in the Asian market." According to the Natural Blue Resources' Chairman and CEO Toney Anaya, "The worldwide demand for recycled steel is presenting an exciting opportunity for our company to aggressively pursue this market. Recycling is a recurring theme of Natural Blue Resources and its subsidiaries as we integrate various "green space" industries in our business growth strategy." Anaya added, "The addition of global opportunities in the recycled steel business will be a focal point of our company. Natural Blue Steel has begun to assemble an impressive customer list and management believes Natural Blue Steel will remain active in the near term following this first shipment to our customers in China." Natural Blue Resources, Inc. is a publicly traded company (OTCBB:NTUR). The Ecowave technology is exclusive to NTUR worldwide excluding S.Korea, where it was developed and is now in full operational use.
---------------------------
(OTCBB: VSRV - Voiceserve, Inc.)
LATEST NEWS!!
Voiceserve Will Be Launching The Voipswitch Blackberry Dialer At The GSMA
Voiceserve is First Time Exhibitor at 2010 Barcelona GSMA Mobile World Congress February 15-18
LONDON, Feb 08, 2010 -- Voiceserve, Inc. (OTCBB: VSRV), a low-cost, next-generation Internet Telephony software and service provider, today announced its participation as an exhibitor at the 2010 Barcelona GSMA Mobile World Congress February 15-18. The GSMA represents the interests of the worldwide mobile communications industry uniting the world's mobile operators, handset makers, software companies, equipment providers, Internet companies and media organizations. Its annual convention is the largest mobile event of the year drawing approximately 50,000 attendees. This is Voiceserve, Inc's first participation in the convention and is one of the only companies exhibiting a mobile VoIP dialer out of the 1,300 companies displaying their cutting-edge products and technology at the annual GSMA Mobile Congress. Voiceserve's booth is located in the UK pavilion at Stand 1F61.
Voiceserve creates the opportunity for ISP's, VoIP resellers and business entrepreneurs to establish a VoIP telephony enterprise. Voiceserve's Voipswitch license has expanded its range of modules to include the full range of mobile dialers. The Voiceserve Voipswitch Mobile dialer is a simple software package that enables regular cell phone users to make calls using a mobile phone via an Internet connection. Voiceserve has developed a simple module which is downloadable onto most mobile phone units. A mobile dialer may be used by companies attempting to reduce operational costs or by individuals who simply want to save money on their monthly cell phone bill. Once the dialer has been downloaded onto the unit, the phone has the capacity to make a call either via the 3G, edge or WIFI connection thus reducing the costs dramatically.
The Voipswitch Dialer range caters for the Symbian (Nokia), Windows(R) and Android phones. At the convention Voiceserve will be launching its VoIP dialer for Blackberry, a feature which will enable wide spread Blackberry users globally.
In addition to making a VoIP phone call through a mobile phone, Voiceserve is one of the first to provide users all the cellular features to which they have become accustomed including SMS text, conference call, call waiting, video conferencing, voice mail and call forwarding. Michael Bibelman, Voiceserve's CEO, commented, "Our software and its broad spectrum of modules creates the opportunity for the masses to become VoIP resellers giving clients access to VoIP telephony from the wide range of mobile units. With the launch of the Blackberry dialer, our range of mobile dialers is complete. We are very excited to have the opportunity to exhibit at the GSMA thus giving our company the chance to significantly boost our visibility in the market. While we have a highly active internal sales effort as well as an external effort through over 30 wholesale relationships, we find attendance at conventions a powerful opportunity to stand out. Consequently, this year we plan to attend eight of the largest telecommunications conventions around the world which is twice the number of conventions we attended in 2009." About Voiceserve, Inc.
VoiceServe is a software platform provider focusing primarily on delivering affordable, complete, next generation services to Internet Telephony Providers (ITSPs). Products include VoipSwitch, a custom modular all-in-one Voice over Internet Protocol (VoIP) management platform licensing solution for resellers; VoIP airtime minutes bundled with optional convenient features, including virtual numbers, direct dial, web callback, and call forwarding; IP-PBX; and mobile softphone, and video technologies. For further information please visit www.voiceserve.com.
---------------------------
About StockHunter.us
StockHunter.us is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockHunter.us. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.
((Comments on this story may be sent to info@m2.com))
(c) 2010 M2 COMMUNICATIONS
[ InfoTech Spotlight's Homepage ]
|
